Emily Carlton, SAF Policy Specialist at LanzaJet, at the 2024 BIO International Convention in San Diego

BIO 2024: Education can improve regulation, biotech innovators say

With rapid innovations in agriculture, energy, and environmental biotech, the industry must try ...
Read More
women's health investment panel at the 2024 BIO International Convention in San Diego

BIO 2024: Investing in women’s health is an untapped gold mine

Investing in women’s health is a gold mine that few healthcare investors have ...
Read More
IMG_7310

We can eliminate cervical cancer in our lifetime – here’s how

In August 2020, the World Health Organization (WHO) adopted a global strategy to ...
Read More
HPV vaccine

FDA approves Arexvy for patients 50–59

On June 7, the U.S. Food and Drug Administration (FDA) approved an expanded ...
Read More
BIO 2024 panel on PDABs and the Inflation Reduction Act

BIO 2024: PDABs and IRA pose a murky threat to patient access

With the passage of the Inflation Reduction Act (IRA) and the growing number ...
Read More
IMG_7321

ARPA-H offers fast, flexible support to biotech startups, panelists tell BIO 2024

Getting government support for a biotech startup no longer need be a slow ...
Read More

EDITORS' CHOICE

IMG_7289

FDA’s Dr. Califf talks supply chains, clinical trial diversity, and America’s health

Biopharma supply chains, streamlining regulation, and other critical issues came up when the leader of the U.S. agency regulating drugs spoke with the leader of ...
Read More

LATEST NEWS

Agriculture

BIO 2024: Education can improve regulation, biotech innovators say

With rapid innovations in agriculture, energy, and environmental biotech, the industry must try to educate regulators and the public about the latest scientific advances and ...
BIO Events

BIO 2024: Investing in women’s health is an untapped gold mine

Investing in women’s health is a gold mine that few healthcare investors have yet to tap, according to a new study that has come out ...
BIO Events

We can eliminate cervical cancer in our lifetime – here’s how

In August 2020, the World Health Organization (WHO) adopted a global strategy to eliminate cervical cancer in our lifetime.  “To eliminate cervical cancer,” according to ...
Health

FDA approves Arexvy for patients 50–59

On June 7, the U.S. Food and Drug Administration (FDA) approved an expanded age indication for GSK’s Arexvy, making it the first respiratory syncytial virus ...
BIO Events

BIO 2024: PDABs and IRA pose a murky threat to patient access

With the passage of the Inflation Reduction Act (IRA) and the growing number of prescription drug affordability boards (PDABs), patients and the biotech industry are ...

Welcome, John F. Crowley!

Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.

AGRICULTURE

Climate Change

Federal Policy

State Policy

International

Bio's View

GET DAILY BIOTECH NEWS IN YOUR INBOX

Scroll to Top
SUBSCRIBE TO THE FREE GOOD DAY BIO NEWSLETTER